Oral bacteria that migrate to the gut can generate metabolites that reach the brain and accelerate Parkinson’s disease.

For decades, Parkinson’s disease has been framed as a straightforward story about dying brain cells and dwindling dopamine. A ...

A research team led by McGill University has taken a close look at a long-standing idea about Parkinson’s disease and found ...

Enrollment will begin in January 2026 Participants will be treated with buntanetap for 36 months The study aims to enroll 500 patients MALVERN, Pa., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc.

In the brain, alpha-synuclein is known for forming clumps called Lewy bodies, which damage brain cells and lead to diseases ...

Parkinson's disease affects more than 1.1 million people in the U.S. Early treatment of obstructive sleep apnea -- a condition that causes breathing to briefly pause -- may decrease the risk of ...

Those with the sleep condition were more likely to develop Parkinson’s disease. But one treatment was found to help. By Caroline Hopkins Legaspi In a study published Monday in JAMA Neurology, ...

As it stands, Parkinson's disease is currently incurable. It's also progressive, which means over time it gets worse and symptoms build up. Patients usually aren't diagnosed until later stages, when ...

The U.S. Food and Drug Administration is reviewing a new Parkinson’s disease drug called tavapadon that could give people with the disease more control over their movements. If approved, it would be ...

Parkinson's disease is on the rise, with U.S. diagnoses expected to reach 1.2 million by 2030. As the most common movement disorder and second most common neurodegenerative disorder, Parkinson's ...

Submission supported by data from the Phase 3 TEMPO program that demonstrated symptomatic improvement across the Parkinson's disease spectrum Positive results across all three Phase 3 TEMPO trials ...